Microchip Technology Announces Record Financial Results for Second Quarter of Fiscal Year 2023
|
RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES |
| |
| | Three Months Ended September 30, | | Six Months Ended September 30, |
| | | 2022 | | | | 2021 | | | | 2022 | | | | 2021 | |
| Research and development expenses, as reported | $ | 268.6 | | | $ | 246.2 | | | $ | 537.6 | | | $ | 484.6 | |
| Share-based compensation expense | | (19.8 | ) | | | (26.1 | ) | | | (39.9 | ) | | | (52.7 | ) |
| Acquisition-related | | (0.2 | ) | | | (0.2 | ) | | | (0.4 | ) | | | (0.4 | ) |
| Non-GAAP research and development expenses | $ | 248.6 | | | $ | 219.9 | | | $ | 497.3 | | | $ | 431.5 | |
| Non-GAAP research and development expenses as a percentage of net sales | | 12.0 | % | | | 13.3 | % | | | 12.3 | % | | | 13.4 | % |
